Spectranetics' lead locking device is CE-marked and approved in Canada:
This article was originally published in Clinica
Executive Summary
Spectranetics has CE-marked its lead locking device (LLD) which has also been approved for marketing in Canada. The disposable, single-use product is designed to act as a stable traction platform during the removal of leads from cardiac pacemakers and implantable cardioverter defibrillators. The LLD is used in conjunction with laser-assisted lead removal products and is available in three sizes. According to the Colorado Springs, Colorado-based company, approximately 5%-10% of the 500,000 pacemaker and defibrillator leads implanted each year need to be extracted due to fracture or abandonment.